Dennis L. Cooper MD

Professor of Medicine (Hematology)

Clinical Interests

Bone marrow transplant (including stem cell support); cutaneous T-cell lymphoma (CTCL); head and neck cancer; lymphoma; Hodgkin's disease; multiple myeloma

Board Certifications

1983
Internal Medicine, Board Certified
1986
Medical Oncology, Board Certified

Patient Care Locations

dennis_cooperfaculty-clinicsfalsetruetrue6truefalsefalse

Clinical Trials

ConditionsStudy Title
Smoldering MyelomaA Phase 2 Biomarker Study of Elotuzumab (Humanized anti-CS1 Monoclonal IgG1 Antibody) Monotherapy to Assess the Association Between NK Cell Status and Efficacy in High Risk Smoldering Myeloma
Follicular LymphomaA Multicenter, Open Label, Phase II Study of Bendamustine and Rituximab followed by 90-yttrium (Y) Ibritumomab Tiuxetan for Untreated Follicular Lymphoma (Fol-BRITe)
LymphomaImaging the Effects of R-CHOP and other Anthracycline containing Chemotherapy on Cognitive Function in Patients with high-grade lymphoma

Edit Profile